Liver Cancer Diagnostics Market Trends

Liver Cancer Diagnostics Market Trends

Increasing prevalence of liver cancer is accelerate the demand for liver cancer diagnostics across the globe. Chronic infections with hepatitis B virus (HBV) and hepatitis C virus (HCV) are major risk factors for liver cancer. The global burden of these infections is significant, and individuals with chronic hepatitis B or C are at a higher risk of developing liver cancer. For instance, according to the CDC data, in 2021, around 296 million people were suffering from hepatitis B and is projected to increase in the near future. Additionally, 25% of chronic hepatitis B infections progress to liver cancer thereby augmenting the product demand. The increasing prevalence of these infections contributes to the growing pool of individuals who require liver cancer diagnostics.
 

Growing adoption of unhealthy diet including excessive fat and sugar content coupled with lack of physical exercise and consumption of excessive alcohol has escalated the number of people suffering from chronic conditions such as diabetes and cancer. The growing prevalence of obesity and metabolic syndrome worldwide contributes to the rising incidence of liver cancer and drives the need for liver cancer diagnostics. Early detection and diagnosis of liver cancer play a crucial role in improving patient outcomes by enabling timely treatment interventions. The growing demand for liver cancer diagnostics is propelled by the need to detect liver cancer at an early stage, assess its severity, and guide appropriate treatment strategies.